Possible involvement of apoptosis was investigated in pathotoxin-treated and nutritionally-depleted in vitro cultured calli by comparing levels of p53-like protein. Antibodies raised against human p53 were used to detect and quantify p53 in B. campestris. Expression of p53-like protein increased from proliferating to static growth stage and reached to constant level at decaying stage. Both ELISA and dot immuno-binding assay showed that p53-like protein was over expressed in toxin treated and nutritionally depleted calli. Almost similar changes were seen in senescent damage in Brassica species indicating involvement of p53 dependent pathways.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
TAp73 and ΔTAp73 isoforms show cell-type specific distributions and alterations in cancer.
Sci Rep
December 2024
Research Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic.
Article Synopsis
- - TP73, part of the TP53 gene family, produces different protein variants (TAp73 and ΔTAp73) with opposing functions through various genetic mechanisms.
- - Newly developed antibodies for these p73 variants reveal that TAp73 is present in multiciliated epithelial cells, while ΔTAp73 marks non-proliferative basal cells in squamous epithelium.
- - In cervical squamous cell carcinomas, p73α is commonly expressed and linked to lower tumor grades, whereas TAp73 appears less frequently and does not show significant associations with cancer characteristics.
Prognostic impact of EGFR expression and immunohistochemistry-based "molecular classification" in bladder cancer.
Ann Diagn Pathol
December 2024
Department of Pathology, Rize Recep Tayyip Erdogan University Faculty of Medicine, Rize, Turkey.
Recent genomic studies emphasize the necessity of molecular classification to reflect diverse clinical and pathological characteristics of bladder cancer. Immunohistochemically bladder cancer can be classified into molecular subtypes, including basal, luminal, and p53-like subtypes. Epidermal growth factor receptor (EGFR) is frequently expressed in basal-type bladder cancers and is associated with poor prognosis.
View Article and Find Full Text PDFHdm2 disrupts HdmX-mediated nuclear export of p53 by sequestering it in nucleus.
Exp Cell Res
August 2024
MOE Key Laboratory of Laser Life Science & Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, School of Optoelectronic Science and Engineering, South China Normal University, Guangzhou, 510631, China. Electronic address:
Dysfunction of the tumor suppressor p53 occurs in most human cancers, Hdm2 and HdmX play critical roles in p53 inactivation and degradation. Under unstressed conditions, HdmX binds to p53 like Hdm2, but HdmX cannot directly induce p53 degradation. Moreover, HdmX has been reported to stimulate Hdm2-mediated ubiquitination and degradation of p53.
View Article and Find Full Text PDFThe stem cell niche transcription factor ETHYLENE RESPONSE FACTOR 115 participates in aluminum-induced terminal differentiation in Arabidopsis roots.
Plant Cell Environ
November 2024
Department of Biochemistry, University of California-Riverside, Riverside, California, USA.
Article Synopsis
- Aluminum exposure halts root growth by activating a DNA damage response pathway, particularly involving the transcription factor SOG1, which leads to root cell death and differentiation.
- Transcriptomic studies have identified targets regulated by SOG1, revealing that the transcription factor ERF115 plays a crucial role in transitioning roots from active growth to terminal differentiation when exposed to aluminum.
- The research indicates that ERF115, along with similar proteins, is essential for the root's response to aluminum toxicity, highlighting a conserved mechanism across different plant species.
ITIH5, as a predictor of prognosis and immunotherapy response for P53-like bladder cancer, is related to cell proliferation and invasion.
Mol Omics
October 2023
Department of Urology, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou 450003, China.
p53-like bladder cancer (BLCA) is a bladder cancer subtype that is resistant to cisplatin-based chemotherapy. The ideal treatment modality for such tumors remains poorly defined, and immunotherapy seems to be a potential approach. Therefore, it is significant to understand the risk stratification of p53-like BLCA and identify novel therapeutic targets.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!